Autopsy report · NCT01251354

Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy

“The futility analysis of study NCT00910091 in patients with endometrial cancer shows that the primary endpoint will not be reached.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 8 months before it stopped.
• 6 participants enrolled.
• Results were posted on the registry 4 years 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Ipsen

Sponsor type

Industry

Conditions

Endometrial Cancer

Interventions

BN83495

Participants

6

Sites

9

Countries

Canada, United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.